| HOME >> BIOLOGY >> TECHNOLOGY |
Net cash used in financing activities (78.0) (24.5)
Effect of exchange rates on cash and
cash equivalents 4.0 4.0
Change in cash and cash equivalents 9.6 11.5
Cash and cash equivalents-beginning of period 75.2 57.6
Cash and cash equivalents-end of period $84.8 $69.1
* Prior period amounts have been adjusted due to an immaterial error
related to depreciation expense and additions to property, plant and
equipment.
BECKMAN COULTER, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(in millions)
(unaudited)
September 30, December 31,
2007 2006
Assets
Current assets
Cash and cash equivalents $84.8 $75.2
Trade and other receivables, net 666.9 671.5
Inventories 520.1 455.8
Deferred income taxes 82.1 83.2
Prepaids and other current assets 67.5 52.4
Total current assets 1,421.4 1,338.1
Property, plant and equipment, net 820.4 721.0
Goodwill 680.8 672.7
Other intangible assets, net 381.1 397.4
Other assets 146.9 162.5
Total assets $3,450.6 $3,291.7
Liabilities and Stockholders' Equity
Current liabilities
Accounts payable
'/>"/>
| SOURCE Beckman Coulter, Inc. Copyright©2007 PR Newswire. All rights reserved |